PHENYLKETONURIA (PKU)
Clinical trials for PHENYLKETONURIA (PKU) explained in plain language.
Never miss a new study
Get alerted when new PHENYLKETONURIA (PKU) trials appear
Sign up with your email to follow new studies for PHENYLKETONURIA (PKU), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill for PKU shows promise in teen trial
Disease control CompletedThis study tested an experimental drug called JNT-517 in 14 teenagers with phenylketonuria (PKU), a genetic condition that causes harmful buildup of an amino acid. Participants took either the drug or a placebo twice daily for 28 days to check safety and how the body processes it…
Matched conditions: PHENYLKETONURIA (PKU)
Phase: PHASE2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New PKU pill tested for taste and tummy troubles
Disease control CompletedThis study tested how well people with PKU (a genetic condition) accept a new protein substitute called PKU EASY Microtabs Plus. Ten participants aged 3 and older took the product for one week. Researchers measured gut symptoms, how much of the product was actually taken, and how…
Matched conditions: PHENYLKETONURIA (PKU)
Phase: NA • Sponsor: Galen Limited • Aim: Disease control
Last updated May 13, 2026 15:58 UTC